293 related articles for article (PubMed ID: 7559308)
21. Assessment of symptom exacerbations in a longitudinal study of children with Tourette's syndrome or obsessive-compulsive disorder.
Lin H; Yeh CB; Peterson BS; Scahill L; Grantz H; Findley DB; Katsovich L; Otka J; Lombroso PJ; King RA; Leckman JF
J Am Acad Child Adolesc Psychiatry; 2002 Sep; 41(9):1070-7. PubMed ID: 12218428
[TBL] [Abstract][Full Text] [Related]
22. A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder.
Nicolson R; Craven-Thuss B; Smith J; McKinlay BD; Castellanos FX
J Am Acad Child Adolesc Psychiatry; 2005 Jul; 44(7):640-6. PubMed ID: 15968232
[TBL] [Abstract][Full Text] [Related]
23. Risperidone in the treatment of affective illness and obsessive-compulsive disorder.
Jacobsen FM
J Clin Psychiatry; 1995 Sep; 56(9):423-9. PubMed ID: 7545159
[TBL] [Abstract][Full Text] [Related]
24. Psychopathological problems in children affected by tic disorders - study on a large Italian population.
Cardona F; Romano A; Bollea L; Chiarotti F
Eur Child Adolesc Psychiatry; 2004 Jun; 13(3):166-71. PubMed ID: 15254844
[TBL] [Abstract][Full Text] [Related]
25. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
Singer HS; Brown J; Quaskey S; Rosenberg LA; Mellits ED; Denckla MB
Pediatrics; 1995 Jan; 95(1):74-81. PubMed ID: 7770313
[TBL] [Abstract][Full Text] [Related]
26. Demographic and clinical features of obsessive-compulsive disorder in children and adolescents.
Hanna GL
J Am Acad Child Adolesc Psychiatry; 1995 Jan; 34(1):19-27. PubMed ID: 7860451
[TBL] [Abstract][Full Text] [Related]
27. Obsessive-compulsive disorder in youth with and without a chronic tic disorder.
Storch EA; Stigge-Kaufman D; Marien WE; Sajid M; Jacob ML; Geffken GR; Goodman WK; Murphy TK
Depress Anxiety; 2008; 25(9):761-7. PubMed ID: 17345600
[TBL] [Abstract][Full Text] [Related]
28. Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder.
Coffey BJ; Biederman J; Geller DA; Spencer TJ; Kim GS; Bellordre CA; Frazier JA; Cradock K; Magovcevic M
J Am Acad Child Adolesc Psychiatry; 2000 May; 39(5):556-61. PubMed ID: 10802972
[TBL] [Abstract][Full Text] [Related]
29. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders.
Steingard R; Biederman J; Spencer T; Wilens T; Gonzalez A
J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):350-3. PubMed ID: 8444764
[TBL] [Abstract][Full Text] [Related]
30. Anxiety disorders and tic severity in juveniles with Tourette's disorder.
Coffey BJ; Biederman J; Smoller JW; Geller DA; Sarin P; Schwartz S; Kim GS
J Am Acad Child Adolesc Psychiatry; 2000 May; 39(5):562-8. PubMed ID: 10802973
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological treatment of tic disorders and Tourette Syndrome.
Roessner V; Schoenefeld K; Buse J; Bender S; Ehrlich S; Münchau A
Neuropharmacology; 2013 May; 68():143-9. PubMed ID: 22728760
[TBL] [Abstract][Full Text] [Related]
32. Tourette's disorder: epidemiology and comorbidity in primary school children.
Kadesjö B; Gillberg C
J Am Acad Child Adolesc Psychiatry; 2000 May; 39(5):548-55. PubMed ID: 10802971
[TBL] [Abstract][Full Text] [Related]
33. [Care continuity for patients with tic disorders during transition from childhood to adulthood].
Kano Y
Nihon Rinsho; 2010 Jan; 68(1):114-8. PubMed ID: 20077801
[TBL] [Abstract][Full Text] [Related]
34. Open trial of risperidone in 24 young children with pervasive developmental disorders.
Masi G; Cosenza A; Mucci M; Brovedani P
J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1206-14. PubMed ID: 11589534
[TBL] [Abstract][Full Text] [Related]
35. Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts.
Budman C; Coffey BJ; Shechter R; Schrock M; Wieland N; Spirgel A; Simon E
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):509-15. PubMed ID: 18928415
[TBL] [Abstract][Full Text] [Related]
36. A placebo-controlled trial of risperidone in Tourette syndrome.
Scahill L; Leckman JF; Schultz RT; Katsovich L; Peterson BS
Neurology; 2003 Apr; 60(7):1130-5. PubMed ID: 12682319
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome.
McCracken JT; Suddath R; Chang S; Thakur S; Piacentini J
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):501-8. PubMed ID: 18928414
[TBL] [Abstract][Full Text] [Related]
38. Videotape tic counts in the assessment of Tourette's syndrome: stability, reliability, and validity.
Chappell PB; McSwiggan-Hardin MT; Scahill L; Rubenstein M; Walker DE; Cohen DJ; Leckman JF
J Am Acad Child Adolesc Psychiatry; 1994; 33(3):386-93. PubMed ID: 8169184
[TBL] [Abstract][Full Text] [Related]
39. [Tic syndrome].
Czapliński A; Steck AJ; Fuhr P
Neurol Neurochir Pol; 2002; 36(3):493-504. PubMed ID: 12185806
[TBL] [Abstract][Full Text] [Related]
40. Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD.
Steingard RJ; Goldberg M; Lee D; DeMaso DR
J Am Acad Child Adolesc Psychiatry; 1994; 33(3):394-9. PubMed ID: 8169185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
